WAYNE GOODMAN to Clomipramine
This is a "connection" page, showing publications WAYNE GOODMAN has written about Clomipramine.
Connection Strength
0.254
-
A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2004; 65 Suppl 14:6-10.
Score: 0.059
-
Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry. 1997; 58 Suppl 5:32-49.
Score: 0.036
-
Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry. 1992 Jul; 31(4):746-50.
Score: 0.026
-
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. Int Clin Psychopharmacol. 1992 Jun; 7 Suppl 1:35-8.
Score: 0.026
-
Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr; 53 Suppl:29-37.
Score: 0.026
-
Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull. 1990; 26(1):54-9.
Score: 0.022
-
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord. 2010 Feb; 121(1-2):175-9.
Score: 0.021
-
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1997 Sep; 154(9):1293-5.
Score: 0.009
-
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994 Mar; 55 Suppl:24-31.
Score: 0.007
-
The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 1993 May; 26 Suppl 1:24-9.
Score: 0.007
-
Acute exacerbation of body dysmorphic disorder during tryptophan depletion. Am J Psychiatry. 1992 Oct; 149(10):1406-7.
Score: 0.007
-
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. 1992 Apr; 53 Suppl:17-28.
Score: 0.006